event,time
72 years old , 0
    male , 0
    hypertension , 0
    type-2 diabetes mellitus , 0
    peripheral arterial disease of the lower limbs , 0
    previous coronary artery bypass graft surgery , 0
    admitted to a tertiary referral hospital , 0
    dry cough , -720
    fever , -720
    anorexia , -720
    loss of more than 10% of body weight , -720
    dyspnea , -720
    hypotensive , 0
    blood pressure 78/53 mmHg , 0
    tachycardic , 0
    heart rate 122 bpm , 0
    feverish , 0
    axillary temperature 38.4°C , 0
    jugular turgor at 45° , 0
    bibasilar pulmonary rales , 0
    new systolic mitral regurgitation murmur , 0
    murmur grade 4 , 0
    cardiorespiratory collapse , 0
    mechanical ventilation , 0
    continuous infusion of vasopressors , 0
    oliguria , 0
    urine output <0.5 mL/kg/h , 0
    signs of poor peripheral perfusion , 0
    cold extremities , 0
    cyanosis , 0
    capillary refill time >2 sec ,%0
    transferred to the intensive care unit , 0
    chest x-ray , 0
    pulmonary congestion , 0
    cardiomegaly , 0
    complete blood count , 0
    leukocytosis , 0
    12920 White blood cells/mm3 , 0
    normocytic anemia , 0
    hemoglobin level of 11.3 g/dL , 0
    erythrocyte sedimentation rate , 0
    91 mm/h , 0
    C-reactive protein plasma levels , 0
    6.8 mg/dL , 0
    transesophagic echocardiography , 0
    mitral valve thickening , 0
    infectious etiology , 0
    large flail of the anterior leaflet , 0
    mitral regurgitant jet intensity , 0
    severe insufficiency , 0
    lung ultrasound , 0
    bilateral multiple B-lines , 0
    diffuse pattern , 0
    pulmonary edema , 0
    definitive diagnosis of mitral native valve endocarditis , 0
    cardiogenic shock , 0
    severe acute mitral valve regurgitation , 0
    empirical antimicrobial therapy , 0
    ceftriaxone , 0
    gentamicin , 0
    hemodynamic instability , 0
    norepinephrine , 0
    doses up to 1.0 μg/kg/min , 0
    intra-aortic balloon pump counterpulsation implant , 0
    emergency mitral valve replacement surgery , 0
    preoperative mortality risk euroscore II 55.2% , 0
    bioprosthetic mitral valve , 0
    progressive improvement in cardiogenic shock , 0
    gradual reduction of the vasopressor dose , 0
    Gemella morbillorum isolated , 0
    blood cultures , 0
    susceptibility testing , 0
    sensitive to penicillin , 0
    ceftriaxone , 0
    vancomycin , 0
    antibiotic regimen de-escalonated , 0
    penicillin G , 0
    gentamicin , 0
    dependent on mechanical ventilation , 0
    critical illness polyneuropathy , 0
    refractory pulmonary congestion , 0
    tracheostomy , 0
    continuous ultrafiltration , 0
    negative fluid balance , 0
    new episode of shock , 648
    pulmonary edema , 648
    lung compliance worsening , 648
    mechanical ventilation with high pressures , 648
    high fraction of inspired oxygen , 648
    transesophagic echocardiography , 648
    bioprosthetic mitral valve thickening , 648
    severe stenosis , 648
    emergency surgery for valve replacement , 648
    death , 648
